慶應義塾大学学術情報リポジトリ(KOARA)KeiO Associated Repository of Academic resources

慶應義塾大学学術情報リポジトリ(KOARA)

Home  »»  Listing item  »»  Detail

Detail

Item Type Article
ID
KAKEN_20K16904seika  
Preview
Image
thumbnail  
Caption  
Full text
KAKEN_20K16904seika.pdf
Type :application/pdf Download
Size :327.4 KB
Last updated :Dec 23, 2024
Downloads : 61

Total downloads since Dec 23, 2024 : 61
 
Release Date
 
Title
Title 小児骨肉腫におけるBRCAnessと化学療法感受性に関する検討  
Kana ショウニ コツニクシュ ニ オケル BRCAness ト カガク リョウホウ カンジュセイ ニ カンスル ケントウ  
Romanization Shōni kotsunikushu ni okeru BRCAness to kagaku ryōhō kanjusei ni kansuru kentō  
Other Title
Title Analysis of BRCAness as a predictive biomarker of neoadjuvant chemotherapy in childhood, adolescents, and young adults with osteosarcomas  
Kana  
Romanization  
Creator
Name 山崎, 文登  
Kana ヤマザキ, フミト  
Romanization Yamazaki, Fumito  
Affiliation 慶應義塾大学・医学部 (信濃町) ・助教  
Affiliation (Translated)  
Role Research team head  
Link 科研費研究者番号 : 70529354

Name 市川, 仁  
Kana イチカワ, ヒトシ  
Romanization Ichikawa, Hitoshi  
Affiliation  
Affiliation (Translated)  
Role Collaborator  
Link  

Name 三谷, 幸代  
Kana ミタニ, サチヨ  
Romanization Mitani, Sachiyo  
Affiliation  
Affiliation (Translated)  
Role Collaborator  
Link  

Name  
Kana  
Romanization  
Affiliation  
Affiliation (Translated)  
Role  
Link  
Edition
 
Place
 
Publisher
Name  
Kana  
Romanization  
Date
Issued (from:yyyy) 2022  
Issued (to:yyyy)  
Created (yyyy-mm-dd)  
Updated (yyyy-mm-dd)  
Captured (yyyy-mm-dd)  
Physical description
1 pdf  
Source Title
Name 科学研究費補助金研究成果報告書  
Name (Translated)  
Volume  
Issue  
Year 2021  
Month  
Start page  
End page  
ISSN
 
ISBN
 
DOI
URI
JaLCDOI
NII Article ID
 
Ichushi ID
 
Other ID
 
Doctoral dissertation
Dissertation Number  
Date of granted  
Degree name  
Degree grantor  
Abstract
小児・AYA世代骨肉腫に、BRCA1/2変異はないが同様の相同組み換え修復機能の異常の関与が考えられるBRCAnessが存在すると考え、24例を対象にSNPアレイ・エクソーム解析でコピー数異常に着目したLOH(loss of heterozygosity)スコア(大領域のLOHの個数)を算出した。骨肉腫のSNPアレイのLOHスコアはBRCA1/2が不活性化した乳がんと同等の水準であった。エクソーム解析の結果も含めて、術前化学療法の感受性が良好と判断される腫瘍壊死率が高い症例では腫瘍壊死率が低い症例に比べてLOHスコアが有意に高かった(20.8 vs 14.9, P=0.023)。
Homologous recombination deficiency (HRD), mainly due to BRCA1/2 inactivation, causes many copy number alterations (CNAs) and structural variations (SVs) in breast and ovarian cancer genomes. Furthermore, similar genomic alterations are observed in BRCA1/2-intact cancers. This phenomenon is called "BRCAness." Osteosarcoma (OS) exhibits a high number of CNAs and SVs. Thus, this study aimed to assess genomic alterations in OS from the viewpoint of HRD. Single nucleotide polymorphism array and whole-exome sequencing analyses were performed on 19 and 5 OSs, respectively, from childhood, adolescents, and young adults. The HRD-LOH (loss of heterozygosity) scores in OSs were as high as those reported in breast cancers, and the scores of good responders to neoadjuvant chemotherapy were higher than those of standard responders (20.8 vs. 14.9, P=0.023). The study results indicate that HRD underlies high genomic alterations in OS and the HRD-LOH score is a predictive biomarker for OS treatment.
 
Table of contents

 
Keyword
骨肉腫  

BRCAness  

相同組み換え修復機能  

化学療法感受性  
NDC
 
Note
研究種目 : 若手研究
研究期間 : 2020~2021
課題番号 : 20K16904
研究分野 : 小児血液・腫瘍
 
Language
日本語  

英語  
Type of resource
text  
Genre
Research Paper  
Text version
publisher  
Related DOI
Access conditions

 
Last modified date
Dec 23, 2024 15:20:13  
Creation date
Dec 23, 2024 15:20:13  
Registerd by
mediacenter
 
History
Dec 23, 2024    インデックス を変更
 
Index
/ Public / Grants-in-Aid for Scientific Research / Fiscal year 2021 / Japan Society for the Promotion of Science
 
Related to